There is a great need for the kind of research carried out by this French team. The worst thing that could happen is that the negative results of this trial give governments, healthcare professionals and laypeople the impression that care doesn’t matter.
What should be the gold standard for the care of people diagnosed with Alzheimer’s? And who should provide that care? A team of researchers led by Dr. Fati Nourhashémi at the University Hospital in Toulouse, France set out to answer those questions.